Progyny: Barclays raises target price to $37 from $30
PGNY•Barclays raised its target price for Progyny to $37 from $30.
Related News
ERock Q3 2026 net income swings to $8.9 million from year-earlier loss
EROC•
KeyBanc cuts Nvidia to sector weight from overweight
NVDA•
Embraer signs long-term maintenance services deal with Mexicana
ERJ•
Bread Financial participates in TD Cowen Financials & Fintech Conference
BFH•
Capstone Q3 2026 net loss narrows 70% to $600,000
CAPS•